135 related articles for article (PubMed ID: 32417881)
1. Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease.
Park SH; Kim HJ; Lee CK; Song EM; Kang SB; Jang BI; Kim ES; Kim KO; Lee YJ; Kim EY; Jung YJ; Park SK; Park DI; Ye BD; Jung SA; Yang SK
J Crohns Colitis; 2020 Dec; 14(12):1780-1784. PubMed ID: 32417881
[TBL] [Abstract][Full Text] [Related]
2. Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFα agents: a French nationwide population-based cohort.
Luu M; Benzenine E; Barkun A; Doret M; Michiels C; Degand T; Quantin C; Bardou M
Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1181-1188. PubMed ID: 31617226
[TBL] [Abstract][Full Text] [Related]
3. Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?
Gisbert JP; Chaparro M
J Crohns Colitis; 2023 Jun; 17(6):995-1009. PubMed ID: 36652274
[TBL] [Abstract][Full Text] [Related]
4. Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
Liu Z; Julsgaard M; Zhu X; Martin J; Barclay ML; Cranswick N; Gibson PR; Gearry RB; van der Giessen J; Connor SJ; Rosella O; Grosen A; Toong C; Flanagan E; Wieringa JW; Janneke van der Woude C; Bell SJ;
J Crohns Colitis; 2022 Dec; 16(12):1835-1844. PubMed ID: 35779236
[TBL] [Abstract][Full Text] [Related]
5. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.
Jones CE; Hesseling AC; Tena-Coki NG; Scriba TJ; Chegou NN; Kidd M; Wilkinson RJ; Kampmann B
AIDS; 2015 Jan; 29(2):155-65. PubMed ID: 25535752
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero.
Goulden B; Chua N; Parker E; Giles I
Rheumatology (Oxford); 2022 Oct; 61(10):3902-3906. PubMed ID: 35258557
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe.
Geldenhuys HD; Mearns H; Foster J; Saxon E; Kagina B; Saganic L; Jarrahian C; Tameris MD; Dintwe OB; Van Rooyen M; Luabeya KK; Hussey G; Scriba TJ; Hatherill M; Zehrung D
Vaccine; 2015 Sep; 33(37):4719-26. PubMed ID: 25862299
[TBL] [Abstract][Full Text] [Related]
8. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.
Mansoor N; Scriba TJ; de Kock M; Tameris M; Abel B; Keyser A; Little F; Soares A; Gelderbloem S; Mlenjeni S; Denation L; Hawkridge A; Boom WH; Kaplan G; Hussey GD; Hanekom WA
J Infect Dis; 2009 Apr; 199(7):982-90. PubMed ID: 19236280
[TBL] [Abstract][Full Text] [Related]
10. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
[TBL] [Abstract][Full Text] [Related]
11. Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature.
O'Brien KL; Ruff AJ; Louis MA; Desormeaux J; Joseph DJ; McBrien M; Coberly J; Boulos R; Halsey NA
Pediatrics; 1995 Mar; 95(3):414-8. PubMed ID: 7862483
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.
Saroha M; Faridi MM; Batra P; Kaur I; Dewan DK
Hum Vaccin Immunother; 2015; 11(12):2864-71. PubMed ID: 26431252
[TBL] [Abstract][Full Text] [Related]
13. Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.
Rabie H; Violari A; Duong T; Madhi SA; Josipovic D; Innes S; Dobbels E; Lazarus E; Panchia R; Babiker AG; Gibb DM; Cotton MF;
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1194-200, i. PubMed ID: 21943845
[TBL] [Abstract][Full Text] [Related]
14. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
[TBL] [Abstract][Full Text] [Related]
15. First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world.
Lu J; Zhang X; Xu H; Li Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2080443. PubMed ID: 35687363
[TBL] [Abstract][Full Text] [Related]
16. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
Deeks SL; Clark M; Scheifele DW; Law BJ; Dawar M; Ahmadipour N; Walop W; Ellis CE; King A
Pediatr Infect Dis J; 2005 Jun; 24(6):538-41. PubMed ID: 15933565
[TBL] [Abstract][Full Text] [Related]
17. BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial.
Prentice S; Nassanga B; Webb EL; Akello F; Kiwudhu F; Akurut H; Elliott AM; Arts RJW; Netea MG; Dockrell HM; Cose S;
Lancet Infect Dis; 2021 Jul; 21(7):993-1003. PubMed ID: 33609457
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease.
Cheent K; Nolan J; Shariq S; Kiho L; Pal A; Arnold J
J Crohns Colitis; 2010 Nov; 4(5):603-5. PubMed ID: 21122568
[TBL] [Abstract][Full Text] [Related]
19. [HIV-infection, AIDS and BCG vaccination].
Toida I
Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
[TBL] [Abstract][Full Text] [Related]
20. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
